Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Viscosupplementation Treatment For Arthritis Market Growth From $4.49 Billion In 2026 To $5.97 Billion By 2030 At A CAGR Of 7.4%

The market for viscosupplementation treatments targeting arthritis has experienced robust expansion recently, with projections indicating a rise from $4.18 billion in 2025 to $4.5 billion in 2026, signifying a compound annual growth rate (CAGR) of 7.7%. This historical growth trajectory has been propelled by several key factors, including a greater incidence of osteoarthritis, an expanding elderly demographic, the early clinical acceptance of hyaluronic acid injections, advancements in orthopedic treatment methods, and the widespread availability of injectable therapies for joint conditions.

The market for viscosupplementation therapies aimed at alleviating arthritis is poised for substantial expansion over the upcoming years, projecting a reach of $5.98 billion by 2030 with a compound annual growth rate (CAGR) of 7.4%. This anticipated growth trajectory is underpinned by several key factors, including a burgeoning preference for conservative arthritis interventions, escalating healthcare investments in managing bone and joint ailments, the proliferation of ambulatory orthopedic care centers, a heightened emphasis on enhancing patient well-being, and continuous advancements in the development of viscosupplement products. During this forecast period, prominent market dynamics will encompass a greater acceptance of treatments involving a singular injection, a heightened need for pain relief solutions offering sustained efficacy, the broader availability of less invasive therapeutic options for arthritis, a more concentrated effort on developing formulations that optimize joint lubrication, and an elevated focus on personalized patient care strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30433&type=smp

Viscosupplementation Treatment For Arthritis Market Expansion Supported By Key Demand Factors

The expanding incidence of osteoarthritis is anticipated to stimulate the market for viscosupplementation arthritis treatments. Osteoarthritis, a degenerative joint condition marked by cartilage deterioration, results in discomfort, rigidity, and limited movement. This rise in osteoarthritis is largely attributed to an aging demographic, as joints naturally wear down over time, rendering older individuals more vulnerable. Viscosupplementation offers a therapeutic approach to osteoarthritis by enhancing joint lubrication, alleviating pain, and boosting mobility. Confirming this trend, Springer Nature Group projected in February 2025 that knee osteoarthritis cases stood at 12.94 million for males and 18.80 million for females, with these numbers expected to climb to 18.45 million and 25.60 million, respectively, by 2046. Consequently, the increasing prevalence of osteoarthritis is a significant factor driving the viscosupplementation treatment for arthritis market.

Increased spending on healthcare is poised to accelerate the expansion of the viscosupplementation treatment for arthritis market. This growth in healthcare expenditure is fueled by the rising burden of chronic illnesses that necessitate prolonged medical supervision and ongoing treatment strategies. Enhanced healthcare spending facilitates access to cutting-edge viscosupplementation therapies, supports the development of novel research, and makes effective osteoarthritis management more financially attainable for patients. Illustrating this, the Centers for Medicare & Medicaid Services reported in June 2025 that U.S. national health expenditures surged by 7.5% in 2023, reaching $4.9 trillion or $14,570 per individual, constituting 17.6% of the GDP. Medicare expenditures alone grew by 8.1% to $1,029.8 billion, making up 21% of the total national health expenditures. Therefore, escalating healthcare spending is a key driver behind the market’s growth for viscosupplementation treatment for arthritis.

Viscosupplementation Treatment For Arthritis Market Segment Performance And Strategic Opportunities

The viscosupplementation treatment for arthritis market covered in this report is segmented –

1) By Product Type: Single Injection, Three Injections, Five Injections

2) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Shoulder Osteoarthritis, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Other End-Users

Subsegments:

1) By Single Injection: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid

2) By Three Injections: Standard Hyaluronic Acid, Buffered Hyaluronic Acid, Biofermented Hyaluronic Acid

3) By Five Injections: Cross-Linked High Viscosity Hyaluronic Acid, Extended-Release Hyaluronic Acid, Multi-Dose Hyaluronic Acid

Viscosupplementation Treatment For Arthritis Market Growth Trends Influencing Competitive Dynamics

In the realm of viscosupplementation therapies for arthritis, leading firms are diligently pursuing novel approaches, including the creation of sophisticated hyaluronic acid mixtures aimed at augmenting joint lubrication, alleviating discomfort, and enhancing physical movement. These sophisticated hyaluronic acid preparations represent engineered versions of the natural substance, featuring refined molecular architectures and viscosities to deliver sustained joint lubrication and more potent pain alleviation in the context of arthritis management. As an illustration, during February of 2024, IBSA Group, a pharmaceutical entity headquartered in Switzerland, introduced its SINOVIAL product line, a cutting-edge viscosupplementation option designed for addressing musculoskeletal ailments. This particular product line capitalizes on advanced NAHYCO technology, which efficaciously integrates hyaluronic acid of both high and low molecular weights to facilitate superior joint lubrication and prolonged pain relief. The products are conceived to emulate the inherent characteristics of natural synovial fluid, thereby contributing to improved joint cushioning and shock absorption capabilities. This injectable formulation boasts ideal viscosity and exceptional tolerability, promoting greater patient ease, enhanced mobility, and more effective control over osteoarthritis and various other musculoskeletal conditions.

Viscosupplementation Treatment For Arthritis Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the viscosupplementation treatment for arthritis market are Johnson And Johnson, Sanofi S.A., LG Chem Ltd., Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Zimmer Biomet Holdings Inc., IBSA Group, Bioventus Inc., Fidia Farmaceutici S.p.A., Ferring Pharmaceuticals A/S, Anika Therapeutics Inc., TRB Chemedica International S.A., Laboratoires VIVACY, Seikagaku Corporation, Regen Lab SA, Genzyme Corporation, Medtronic PLC, Orthogenix Inc., Hyundai Pharm Co. Ltd., DePuy Synthes

Access The Complete Viscosupplementation Treatment For Arthritis Market Report:

https://www.thebusinessresearchcompany.com/report/global-viscosupplementation-treatment-for-arthritis-market-report

Viscosupplementation Treatment For Arthritis Market Regional Distribution: Which Areas Drive Market Expansion?

North Americawas the largest region in the viscosupplementation treatment for arthritis market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the viscosupplementation treatment for arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model